Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS

Lainé, A.-L., Price, D., Davis, J. et al. (5 more authors) (2016) Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS. International Journal of Pharmaceutics, 512 (1). pp. 118-125. ISSN 0378-5173

Abstract

Metadata

Authors/Creators:
  • Lainé, A.-L.
  • Price, D.
  • Davis, J.
  • Roberts, D.
  • Hudson, R.
  • Back, K.
  • Bungay, P.
  • Flanagan, N.
Copyright, Publisher and Additional Information: © 2016 Elsevier.
Keywords: Amorphous formulation; Pharmacokinetic study; Mesoporous material; In vitro pH shift assay
Dates:
  • Accepted: 15 August 2016
  • Published (online): 16 August 2016
  • Published: 15 October 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Biological Sciences (Sheffield) > Department of Molecular Biology and Biotechnology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 07 Oct 2019 09:13
Last Modified: 07 Oct 2019 09:13
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.ijpharm.2016.08.034
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics